-
1.发明公开Insulinotropic peptide derivative wherein its N-terminal amino acid is modified 有权胰岛素抵抗剂肽酶修饰剂n末端氨基酸
公开(公告)号：EP2390265A2
公开(公告)日：2011-11-30
申请号：EP11162132.2
申请日：2008-07-16
发明人： Song, Dae Hae , Lim, Chang Ki , Kim, Young Hoon , Kwon, Se Chang , Lee, Gwan Sun , Bae, Sung Min , Jung, Sung Youb
CPC分类号： C07K14/46 , A61K38/26 , C07K14/57563 , C07K14/605
摘要： The present invention relates to an N-terminal amino acid-modified insulinotropic peptide having a high activity, and to a pharmaceutical composition comprising the same. The insulinotropic peptide derivatives according to the present invention exhibit therapeutic effects, which are not observed in native and other insulinotropic peptide analogs. Therefore, the insulinotropic peptide derivatives and the pharmaceutical composition comprising the same according to the present invention can be effectively provided for the treatment of the diseases.
摘要翻译： 本发明涉及具有高活性的N-末端氨基酸修饰的促胰岛素肽及其组合物。 根据本发明的促胰岛素肽衍生物显示出在天然和其他促胰岛素肽类似物中未观察到的治疗效果。 因此，可以有效地提供促胰岛素肽衍生物和包含其的本发明的药物组合物用于治疗疾病。
-
2.发明授权Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same 有权埃索美拉唑晶Strontiumhydrat，过程用于容纳其制备方法和药物组合物
公开(公告)号：EP1780207B1
公开(公告)日：2012-08-15
申请号：EP06013379.0
申请日：2006-06-28
发明人： Ha, Tae Hee , Oh, Hee Sook , Kim, Won Jeoung , Park, Chang Hee Dongho-villa 203 , Kim, Eun Young , Kim, Young Hoon , Suh, Kwee Hyun , Lee, Gwan Sun
IPC分类号： C07D401/12 , A61K31/4439 , A61P1/04
CPC分类号： C07D401/12
-
3.发明公开Insulinotropic peptide derivative wherein its N-terminal amino acid is modified 有权具有修饰的N-末端氨基酸促胰岛素肽衍生物
公开(公告)号：EP2390265A3
公开(公告)日：2012-03-21
申请号：EP11162132.2
申请日：2008-07-16
发明人： Song, Dae Hae , Lim, Chang Ki , Kim, Young Hoon , Kwon, Se Chang , Lee, Gwan Sun , Bae, Sung Min , Jung, Sung Youb
CPC分类号： C07K14/46 , A61K38/26 , C07K14/57563 , C07K14/605
摘要： The present invention relates to an N-terminal amino acid-modified insulinotropic peptide having a high activity, and to a pharmaceutical composition comprising the same. The insulinotropic peptide derivatives according to the present invention exhibit therapeutic effects, which are not observed in native and other insulinotropic peptide analogs. Therefore, the insulinotropic peptide derivatives and the pharmaceutical composition comprising the same according to the present invention can be effectively provided for the treatment of the diseases.
-
-
搜索结果
3 条记录 (耗时 0.009 秒)
